Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > It’s allllllll talk
View:
Post by Dumbeldorfwhite on Aug 30, 2024 11:42pm

It’s allllllll talk

Seriously, how can u guys still drink the kool aid? Here's a post from 2022 talking about the next step being GLP studies yet here they are in almost 2025 and haven't even started them. Been saying it for years have to vote these guys out or hope someone can buy a large enough position to force a seat on the board. Too easy making a cushy salary and then trying to sue posters for calling them out. O by the way I wonder how much that costs shareholders vs how much they recouped from that.

https://stockhouse.com/news/press-releases/2022/11/17/theralase-xae-closes-private-placement-equity-financing
Comment by Dumbeldorfwhite on Aug 30, 2024 11:45pm
For real I can't wait for the next pp. Who wants to bet it's somewhere around 150k
Comment by DJDawg on Aug 31, 2024 9:21am
I've invested and lost money in other biotechs with good ideas (not as good as Dr. McFarland's) where the ceo and leadership were slick but doing the job as a job. Getting paid, buying some small amounts here and there....and then closing down with nice payout for themselves. I'd like to hope that an asset TLT has going for it is the motivation on the part of RDW and Dr.M. RDW is ...more  
Comment by Kayz88 on Aug 31, 2024 10:12am
So I buy into this ramble as well. This is RDW's legacy and it's something he spent a lifetime building. The science is there and I've invested in other biotech stock where they had massive funding but no product. This is the polar opposite where there is little to no funding but an incredibly promising product.  As to why RDW isn't able to raise more money or speculation on ...more  
Comment by N0taP00p on Aug 31, 2024 10:36am
DDW and DJD:  Great posts. The kind of discussion that should happen here. Given the slowing trickle of money with each raise, anything more than 250K would be a nice surprise.  I'd support a pay raise if they actually get this to BTD by early Q4.  My key concerns: A very low raise that gives them a month or two more, and a fuzzy NR that tries to push BTD into 2025.  
Comment by gebremeskel on Aug 31, 2024 7:41pm
Welcome to the new basher heaven Theralase bullboard ! Dumbledorfwhite posts are the new standard for objective discussions. Thanks to Notap00p/BJ and his ilk we have now descended to new depths of entitled whining
Comment by O12009 on Aug 31, 2024 8:12pm
They are not entitled just what the trash man takes out. Please use the ignore button and they will go away. We have a ton of great minds who post fantastic information and the drugs we have in the pipeline will be the new standard of care for cancer patients. Everyone keep hanging tough the fun is right around the corner.
Comment by Alamir1111 on Sep 01, 2024 9:19am
28 more patients to be treated to get to 100 by end of year
Comment by Dumbeldorfwhite on Sep 01, 2024 1:28pm
It's fine we ll just hear more excuses about slow enrollment due to the pandemic which has been over for 2 years. They won't even hit 90 I bet by the end of the year.
Comment by Canucks1717 on Sep 01, 2024 1:31pm
Lol.....Mr negative
Comment by Infinity on Sep 01, 2024 4:41am
A very likely and all familiar scenario that keep repeating itself.  Just next quarter,  hang in there!!  everything is going to be OK!!.  I hope after this raise RDW thinks seriously in terms of a JV instead of going it alone.
Comment by CancerSlayer on Sep 01, 2024 9:50am
From an investor's standpoint, both our partnership/financing options will certainly depend on the amount of this latest raise/tranche.   We shouldn't need a jv to reach BTD. Such a milestone can act as a stronger proof point for big & small suitors, enabling better partnering & funding deals (i.e. royalty/licensing, convertible debt financing).   In terms of partnering ...more  
Comment by Dumbeldorfwhite on Sep 01, 2024 1:27pm
Heavily invested him and his wife are making 650k a year! 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250